Search | Webyourself Social Media Platform

added article Other

2024-07-05 08:58:00 -

Real-World Evidence and Outcomes of Ponatinib HCl API Use

Ponatinib hydrochloride (HCl) API, a tyrosine kinase inhibitor, has emerged as a powerful tool in treating certain types of leukemia. However, its journey since FDA approval has been marked by both promise and controversy. While clinical trials demonstrated its efficacy, real-world evidence (RWE) is crucial for understanding its effectiveness and safety in everyday clinical practice. The...

0 Comments 0 Shares 586 Views 0 Reviews